353
Views
0
CrossRef citations to date
0
Altmetric
Articles

Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology

, , , &
Pages 37-58 | Received 26 Dec 2016, Accepted 08 Dec 2017, Published online: 16 Jan 2018
 

ABSTRACT

Lung cancer is the leading cause of cancer-related mortality with about 1.6 million deaths every year worldwide. Gene mutations and overexpression of oncogenes play a central role in malignant transformation in NSCLC. Conventional approaches for treatments of NSCLC have shown low levels of success while showing severe side effects. Target therapy using siRNA has recently emerged as a new strategy for cancer treatment by specific targeting of genes involved in the development and metastasis of cancer. This article dedicated to an update review of molecular targets could potentially be used for target therapy of lung cancer using SiRNA technology.

Additional information

Funding

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Science. Tabriz, Iran [102895].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.